Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure

Protein Science

Volumn 8, Issue 4, 1999, Pages 741-749

  Tsitsanou, Katerina E ^a   Oikonomakos, Nikos G ^a   Zographos, Spyros E ^a   Skamnaki, Vicky T ^a   Gregoriou, Mary ^b   Watson, Kimberly A ^b   Johnson, Louise N ^b   Fleet, George W J ^b  

^a INSTITUTE OF BIOLOGY   (Greece)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Binding; Cryocrystallography; Cryoprotectant; DMSO; Inhibitor; MPD; Phosphorylase

Indexed keywords

CRYOPROTECTIVE AGENT; DIMETHYL SULFOXIDE; GLUCOSE 1 PHOSPHATE; GLYCOGEN PHOSPHORYLASE; HEXYLENE GLYCOL; MACROGOL;

ARTICLE; BINDING AFFINITY; CRYOPROTECTION; CRYSTALLOGRAPHY; ENZYME ACTIVATION; ENZYME ACTIVITY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

EID: 0032918978     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.8.4.741     Document Type: Article

References (53)

1. Barford D, Hu SH, Johnson LN. 1991. Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP. J Mol Biol 218:233-260.
2. Barford D, Johnson LN. 1989. The allosteric transition of glycogen phosphorylase. Nature 340:609-616.
3. Bichard CJF, Mitchell EP, Wormald MR, Watson KA, Johnson LN, Zographos SE, Koutra DD, Oikonomakos NG, Fleet GWJ. 1995. Potent inhibition of glycogen phosphorylase by a spirohydantoin of glucopyranose: First pyranose analogues of hydantocidin. Tetrahedron Lett 36:2145-2148.
4. Brünger AT. 1992. X-PLOR version 3.1. A system for X-ray crystallography and NMR. New Haven, Connecticut: Yale University Press.
5. Brünger AT. 1996. X-PLOR version 3.8. New Haven, Connecticut: Department of Molecular Biophysics and Biochemistry, Yale University.
6. Collaborative Computational Project, Number 4. 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D 50:760-763.
7. Cohen P. 1973. The subunit structure of rabbit-skeletal-muscle phosphorylase kinase, and the molecular basis of its activation reactions. Eur J Biochem 34:1-14.
8. Dreyfus M, Vandenbunder B, Buc H. 1978. Stabilization of a phosphorylase b active conformation by hydrophobic solvents. FEBS Lett 95:185-189.
9. Fischer EH, Krebs EG. 1962. Muscle phosphorylase b. Methods Enzymol 5:369-373.
10. Fiske CH, Subbarow Y. 1925. The colorimetric determination of phosphorous. J Biol Chem 66:375-400.
11. Garman EF. 1995. Modern methods for rapid X-ray diffraction data collection from crystals of macromolecules. In: Jones C, Mulloy B, Sanderson M, eds. Methods in molecular biology, vol. 56: Crystallographic methods and protocols. Totowa, NJ: Humana Press Inc. pp 87-126.
12. Garman EF, Schneider TR. 1997. Macromolecular cryocrystallography. J Appl Crystallogr 30:211-231.
13. Gregoriou M, Noble MEM, Watson KA, Garman EF, Krulle TM, Fuente C, Fleet GWJ, Oikonomakos NG, Johnson LN. 1998. The structure of a glycogen phosphorylase spirohydantoin complex at 1.8 Å resolution and 100 K: The role of the water structure and its contribution to binding. Protein Sci 7:915-927.
14. Helmreich EJM, Cori CF. 1964. The role of adenylic acid in the activity of phosphorylase. Proc Natl Acad Sci USA 51:131-138.
15. Hope H. 1990. Crystallography of biological macromolecules at ultra-low temperature. Annu Rev Biophys Biophys Chem 19:107-126.
16. Johnson LN. 1992. Glycogen phosphorylase: Control by phosphorylation and allosteric effectors. FASEB J 6:2274-2282.
17. Johnson LN, Hajdu J, Acharya KR, Stuart DI, McLaughlin PJ, Oikonomakos NG, Barford D. 1989, Glycogen phosphorylase b. In: Herve G, ed. Allosteric enzymes. Boca Raton, Florida: CRC Press. pp 81-127.
18. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. 1991. Improved methods for the building of protein models in electron density maps and the location of errors in these models. Acta Crystallogr A47:110-119.
19. Kastenschmidt LL, Kastenschmidt J, Helmreich EJM. 1968. Subunit interactions and their relationship to the allosteric properties of rabbit skeletal muscle phosphorylase b. Biochemistry 7:3590-3608.
20. Kasvinsky PJ, Shechosky S, Fletterick RJ. 1978. Synergistic regulation of phosphorylase a by glucose and caffeine. J Biol Chem 255:9102-9106.
21. Krulle TM, Fuente C, Watson KA, Gregoriou M, Johnson LN, Tsitsanou KE, Zographos SE, Oikonomakos NG, Fleet GWJ. 1997. Stereospecific synthesis of spirohydantoins of β-glucopyranose: Inhibitors of glycogen phosphorylase. Synlett:211-213.
22. Krulle TM, Watson KA, Gregoriou M, Johnson LN, Crook S, Watkin DJ, Griffiths RC, Nasj RJ, Tsitsanou KE, Zographos SE, Oikonomakos NG, Fleet GWJ. 1995. Specific inhibition of glycogen phosphorylase by a spirodiketopiperazine at the anomeric position of glucopyranose. Tetrahedron Lett 36:8291-8294.
23. Lamzin VS, Wilson KS. 1993. Automated refinement of protein models. Acta Crystallogr D49:129-147.
24. Leatherbarrow RJ. 1992. GraFit version 3.0. Staines, UK: Erithakus Software.
25. Martin JL, Johnson LN, Withers SG. 1990. Comparison of the binding of glucose and glucose-1-phosphate derivatives to T state glycogen phosphorylase b. Biochemistry 29:10745-10757.
26. Martin JL, Veluraja K, Johnson LN, Fleet GWJ, Ramsden NG, Bruce I, Oikonomakos NG, Papageorgiou AC, Leonidas DD, Tsitoura HS. 1991. Glucose analogue inhibitors of glycogen phosphorylase: The design of potential drugs for diabetes. Biochemistry 30:10101-10116.
27. Melpidou AE, Oikonomakos NG. 1983. Effect of glucose-6-P on the catalytic and structural properties of glycogen phosphorylase. FEBS Lett 154:105-110.
28. Mitchell EP. 1995. Cryocrystallographic and mechanistic studies on glycogen phosphorylase. Oxford: University of Oxford.
29. Mitchell EP, Garman EF. 1994. Flash freezing of protein crystals: Investigation of mosaic spread and diffraction limit with variation of cryoprotectanl concentration. J Appl Crystallogr 27:1010-1074.
30. Mitchell EP, Withers SG, Emert P, Vasella AT, Garman EF, Oikonomakos NG, Johnson LN. 1996. Ternary complex structures of glycogen phosphorylase with a transition state analogue nojirimycin tetrazole and phosphate in the T and R states. Biochemistry 35:7341-7355.
31. Monod J, Changeux JP, Jacob F. 1965. On the nature of allosteric transitions: A plausible model. J Mol Biol 12:88-118.
32. Murshudov GN, Vagen AA, Dodson EJ. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D53:240-255.
33. Oikonomakos NG, Acharya KR, Johnson LN. 1992. Rabbit muscle glycogen phosphorylase b: Structural basis of activation and catalysis. In: Harding JJ, Crabbe MJC, eds. Post-translational modification of proteins. Boca Raton, Florida: CRC Press, pp 81-151.
34. Oikonomakos NG, Kontou M, Zographos SE, Watson KA, Johnson LN, Bichard CJF, Fleet GWJ, Acharya KR. 1995a. N-Acetyl-β-D-glucopyranosylamine: A potent T state inhibitor of glycogen phosphorylase. A comparison with α-D-glucose. Protein Sci 4:2469-2477.
35. Oikonomakos NG, Melpidou AE, Johnson LN. 1985. Crystallization of pig skeletal phosphorylase b. Purification, physical and catalytic characterization. Biochim Biophys Acta 832:248-256.
36. Oikonomakos NG, Zographos SE, Johnson LN, Papageorgiou AC, Acharya KR. 1995b. The binding of 2-deoxy-glucose-6-phosphate to glycogen phosphorylase b: Kinetic and crystallographic studies. J Mol Biol 254:900-917.
37. Otwinowski Z. 1993. DENZO. Data collection and processing. DL/SC1/R34. Daresbury, Warrington, UK: SERC Laboratory.
38. Owen DJ, Papageorgiou AC, Garman EF, Noble MEM, Johnson LN. 1995. Expression, purification and crystallisation of phosphorylase kinase catalytic domain. J Mol Biol 246:374-381.
39. Perez-Ramirez B, Timasheff SN. 1994. Cosolvent modulation of the tubulin-colchicine GTPase-activating conformational change; strength of the enzymatic activity. Biochemistry 33:6262-6267.
40. Perutz M. 1989. Mechanisms of cooperativity and allosteric regulation in proteins. Q Rev Biophys 22:139-237.
41. Petsko GA. 1975. Protein crystallography at sub-zero temperatures: Cryoprotective mother liquors for protein crystals. J Mol Biol 96:381-392.
42. Read RJ. 1986. Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallogr A 42:140-149.
43. Rogers DW. 1994. Cryocrystallography. Structure 2:1135-1139.
44. Saheki S, Takeda A, Shimazu T. 1985. Assay of inorganic phosphate in the mild pH range, suitable for measurement of glycogen phosphorylase activity. Anal Biochem 148:277-281.
45. Schneider T. 1995. Cryocrystallography at EMBL-Hamburg. A practical guide. Hamburg, Germany: European Molecular Biology Laboratory (EMBL), c/o DESY.
46. Sprang SR, Goldsmith EJ, Fletterick RJ, Withers SG, Madsen NB. 1982. Catalytic site of glycogen phosphorylase: Structure of the T state and specificity for α-D-glucose. Biochemistry 21:5364-5371.
47. Sprang SR, Withers SG, Goldsmith EJ, Fletterick RJ, Madsen NB. 1991. Structural basis for activation of glycogen phosphorylase b by adenosine monophosphate. Science 254:1367-1371.
48. Teng TY. 1990. Mounting of crystals for macromolecular crystallography in a free-standing thin film. J Appl Crystallogr 23:387-391.
49. Uhing RJ, Janski AM, Graves DJ. 1979. The effect of solvents on nucleotide regulation of glycogen phosphorylase. J Biol Chem 254:3166-3169.
50. Uhing RJ, Lentz SR, Graves DJ. 1981. Effects of 1,2-dimethoxyethane on the catalytic and coenzyme properties of glycogen phosphorylase. Biochemistry 20:2537-2544.
51. Watson KA, Mitchell EP, Johnson LN, Cruciani G, Son JC, Bichard CJF, Fleet GWJ, Oikonomakos NG, Kontou M, Zographos SE. 1995. Glucose analogue inhibitors of glycogen phosphorylase: From crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection. Acta Crystallogr D51:458-472.
52. Watson KA, Mitchell EP, Johnson LN, Son JC, Bichard CJF, Orchard MG, Fleet GWJ, Oikonomakos NG, Leonidas DD, Kontou M, Papageorgiou AC. 1994. The design of inhibitors of glycogen phosphorylase: A study of a and β glucoheptonamides and 1-thio-β-D-glucose compounds. Biochemistry 33: 5745-5758.
53. Zographos SE, Oikonomakos NG, Tsitsanou KE, Leonidas DD, Chrysina ED, Skamnaki VT, Bischoff H, Goldman S, Watson KA, Johnson LN. 1997. The structure of glycogen phosphorylase b with an alkyl-dihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor. Structure 5:1413-1425.